Finance

Beta
Lists
033780:KRX
KT&G Corp
â‚©179,300.00
+1.99%
(+3,500.00) 1D
Jun 5, 3:30:11 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 033780...
Open
â‚©179,600
High
â‚©182,600
Low
â‚©177,300
Mkt. cap
18.61T
Avg. vol.
327.78K
Volume
229.26K
Dividend
3.35%
Quarterly dividend
â‚©1,500
Ex-dividend date
Feb 26, 2026
P/E ratio
15.58
52-wk high
â‚©190,000
52-wk low
â‚©119,200
EPS
â‚©11,507
Shares outstanding
103.81M
No. of employees
4K
Open
â‚©179,600
High
â‚©182,600
Low
â‚©177,300
Mkt. cap
18.61T
Avg. vol.
327.78K
Volume
229.26K
Dividend
3.35%
Quarterly dividend
â‚©1,500
Ex-dividend date
Feb 26, 2026
P/E ratio
15.58
52-wk high
â‚©190,000
52-wk low
â‚©119,200
EPS
â‚©11,507
Shares outstanding
103.81M
No. of employees
4K
News stories
From sources across the web
Profile
KT&G Corporation, originally Korea Tobacco & Ginseng, also branded as Korea Tomorrow & Global, is the leading tobacco company in South Korea with annual sales over US$4 billion. KT&G was originally a government-owned monopoly but was privatised and today is publicly traded, competing for market share with other international tobacco firms such as Philip Morris International, British American Tobacco, and Japan Tobacco. KT&G's sales volume share was 62% of the Korean market in 2009. KT&G also owns significant subsidiaries such as Korea Ginseng Corporation, Yungjin Pharm, and several bio ventures. Its headquarters are in Daejeon. Wikipedia
About KT&G Corp
CEOKyung-man Bang
Employees4.4K
FoundedApr 1989
HeadquartersDaejeon, Daedeok-gu, South Korea
SectorTobacco
Websitektng.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.55T
1.83T
1.71T
1.70T
Cost of goods sold
800.40B
933.01B
980.72B
887.77B
Cost of revenue
800.40B
933.01B
980.72B
887.77B
Research and development expenses
13.29B
18.46B
22.29B
15.58B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
342.41B
385.48B
435.33B
397.43B
Operating expense
397.62B
428.60B
490.15B
451.29B
Total operating expenses
1.20T
1.36T
1.47T
1.34T
Operating income
349.88B
465.29B
242.94B
364.54B
Other non operating income
35.35B
-27.26B
-33.53B
-24.40B
EBT including unusual items
188.96B
544.23B
384.68B
508.31B
EBT excluding unusual items
186.99B
544.76B
312.85B
501.46B
Income tax expense
43.98B
128.56B
102.43B
129.76B
Effective tax rate
23.27%
23.62%
26.63%
25.53%
Other operating expenses
24.81B
735.00M
4.59B
4.58B
Net income
143.33B
419.25B
271.88B
380.54B
Net profit margin
9.26%
22.95%
15.86%
22.34%
Earnings per share
1.33K
3.87K
2.66K
-
Interest and investment income
31.92B
31.06B
33.73B
28.24B
Interest expense
-18.50B
-20.20B
-23.10B
-20.39B
Net interest expenses
13.42B
10.86B
10.63B
7.85B
Depreciation and amortization charges
18.01B
18.28B
17.66B
19.97B
EBITDA
420.96B
540.52B
320.53B
442.66B
Gain or loss from assets sale
-4.39B
1.26B
-224.18B
-6.72B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer